(-)-gambogic acid decreases expression ISO AKT2 (Homo sapiens) 6480464 gambogic acid results in decreased expression of AKT2 mRNA CTD PMID:33533530 (1->4)-beta-D-glucan multiple interactions ISO Akt2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of AKT2 mRNA CTD PMID:36331819 (S)-nicotine affects expression EXP 6480464 Nicotine affects the expression of AKT2 mRNA CTD PMID:31972234 (S)-nicotine increases expression ISO Akt2 (Mus musculus) 6480464 Nicotine results in increased expression of AKT2 mRNA CTD PMID:31945395 1,2-dichloroethane increases expression ISO Akt2 (Mus musculus) 6480464 ethylene dichloride results in increased expression of AKT2 mRNA CTD PMID:28189721 and PMID:28960355 1,2-dimethylhydrazine decreases expression EXP 6480464 1 and 2-Dimethylhydrazine results in decreased expression of AKT2 mRNA CTD PMID:32387197 1,2-dimethylhydrazine increases expression ISO Akt2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of AKT2 mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene affects binding ISO AKT2 (Homo sapiens) 6480464 Dinitrochlorobenzene binds to AKT2 protein CTD PMID:32991956 17alpha-ethynylestradiol multiple interactions ISO Akt2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AKT2 mRNA CTD PMID:17942748 17beta-estradiol affects expression ISO AKT2 (Homo sapiens) 6480464 Estradiol affects the expression of AKT2 mRNA CTD PMID:22574217 2,2',4,4'-Tetrabromodiphenyl ether increases phosphorylation EXP 6480464 2 more ... CTD PMID:33581290 2,2',5,5'-tetrachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:23829299 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Akt2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AKT2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Akt2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of AKT2 mRNA CTD PMID:15328365 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Akt2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of AKT2 mRNA CTD PMID:19465110 2-ethoxyethanol increases expression EXP 6480464 2-ethoxyethanol results in increased expression of AKT2 mRNA CTD PMID:19643169 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of AKT2 mRNA CTD PMID:19643169 and PMID:21061450 2-nitrotoluene increases expression EXP 6480464 2-nitrotoluene results in increased expression of AKT2 mRNA CTD PMID:16460773 4,4'-sulfonyldiphenol decreases expression EXP 6480464 bisphenol S results in decreased expression of AKT2 mRNA CTD PMID:26186136 4,4'-sulfonyldiphenol increases expression ISO AKT2 (Homo sapiens) 6480464 bisphenol S results in increased expression of AKT2 protein CTD PMID:34186270 4,4'-sulfonyldiphenol increases phosphorylation EXP 6480464 bisphenol S results in increased phosphorylation of AKT2 protein CTD PMID:37357847 4-nonylphenol increases expression EXP 6480464 4-nonylphenol results in increased expression of AKT2 mRNA CTD PMID:30228064 4-phenylbutyric acid multiple interactions ISO AKT2 (Homo sapiens) 6480464 4-phenylbutyric acid inhibits the reaction [Curcumin results in decreased phosphorylation of AKT2 protein] CTD PMID:36640941 4-vinylcyclohexene dioxide increases expression ISO Akt2 (Mus musculus) 6480464 4-vinyl-1-cyclohexene dioxide results in increased expression of AKT2 mRNA CTD PMID:20829426 5-fluorouracil increases expression ISO AKT2 (Homo sapiens) 6480464 Fluorouracil results in increased expression of AKT2 protein CTD PMID:16803524 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of AKT2 mRNA CTD PMID:31881176 acetylsalicylic acid increases expression ISO AKT2 (Homo sapiens) 6480464 Aspirin results in increased expression of AKT2 mRNA CTD PMID:11906190 acrolein multiple interactions ISO AKT2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of AKT2 mRNA more ... CTD PMID:32699268 and PMID:32845096 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of AKT2 mRNA CTD PMID:31644924 afimoxifene decreases response to substance ISO AKT2 (Homo sapiens) 6480464 AKT2 protein results in decreased susceptibility to afimoxifene CTD PMID:18351453 aldehydo-D-glucose affects response to substance ISO Akt2 (Mus musculus) 6480464 AKT2 protein affects the susceptibility to Glucose CTD PMID:21964073 all-trans-retinoic acid multiple interactions EXP 6480464 [nitrofen co-treated with Tretinoin] results in increased expression of AKT2 mRNA CTD PMID:20623292 allethrin decreases expression EXP 6480464 Allethrins results in decreased expression of AKT2 protein CTD PMID:35742842 alpha-pinene multiple interactions ISO AKT2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of AKT2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of AKT2 mRNA CTD PMID:32699268 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO Akt2 (Mus musculus) 6480464 [TNFSF11 protein co-treated with pyrazolanthrone] results in increased expression of AKT2 mRNA and crocin inhibits the reaction [[TNFSF11 protein co-treated with pyrazolanthrone] results in increased expression of AKT2 mRNA] CTD PMID:30580027 antirheumatic drug increases expression ISO AKT2 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of AKT2 mRNA CTD PMID:24449571 arsane multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AKT2 mRNA and zingerone inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AKT2 mRNA] CTD PMID:36822304 arsenic atom multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AKT2 mRNA and zingerone inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AKT2 mRNA] CTD PMID:36822304 arsenite(3-) increases expression ISO AKT2 (Homo sapiens) 6480464 arsenite results in increased expression of AKT2 mRNA CTD PMID:34425169 arsenous acid decreases response to substance ISO AKT2 (Homo sapiens) 6480464 AKT2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:18048359 benzo[a]pyrene decreases methylation ISO AKT2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of AKT2 5' UTR CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO Akt2 (Mus musculus) 6480464 thymoquinone inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of AKT2 protein] CTD PMID:36193556 benzo[a]pyrene increases phosphorylation ISO Akt2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased phosphorylation of AKT2 protein CTD PMID:36193556 Benzo[k]fluoranthene decreases expression ISO AKT2 (Homo sapiens) 6480464 benzo(k)fluoranthene results in decreased expression of AKT2 mRNA CTD PMID:21635667 berberine multiple interactions ISO Akt2 (Mus musculus) 6480464 Berberine inhibits the reaction [Dexamethasone results in decreased expression of AKT2 mRNA] CTD PMID:20462044 Bergenin multiple interactions ISO Akt2 (Mus musculus) 6480464 bergenin inhibits the reaction [[TNFSF11 protein co-treated with Pyruvaldehyde] results in increased expression of AKT2 mRNA] CTD PMID:31369791 bis(2-chloroethyl) sulfide increases expression ISO Akt2 (Mus musculus) 6480464 Mustard Gas results in increased expression of AKT2 mRNA CTD PMID:18955075 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of AKT2 mRNA CTD PMID:25280772 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of AKT2 mRNA CTD PMID:25181051 more ... bisphenol A increases phosphorylation ISO AKT2 (Homo sapiens) 6480464 bisphenol A results in increased phosphorylation of AKT2 protein CTD PMID:36232920 bisphenol A decreases phosphorylation EXP 6480464 bisphenol A results in decreased phosphorylation of AKT2 protein CTD PMID:38006930 bisphenol A decreases phosphorylation ISO AKT2 (Homo sapiens) 6480464 bisphenol A results in decreased phosphorylation of AKT2 protein CTD PMID:38006930 bisphenol A decreases expression ISO AKT2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of AKT2 protein CTD PMID:34186270 bisphenol A decreases methylation ISO AKT2 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of AKT2 gene CTD PMID:31601247 bisphenol A increases expression ISO AKT2 (Homo sapiens) 6480464 bisphenol A results in increased expression of AKT2 mRNA CTD PMID:33670352 bisphenol A multiple interactions EXP 6480464 bisphenol A analog results in increased expression of and results in increased phosphorylation of AKT2 protein CTD PMID:36214340 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of AKT2 mRNA and bisphenol A results in increased expression of AKT2 protein CTD PMID:24884420 and PMID:27539358 Bisphenol B increases phosphorylation EXP 6480464 bisphenol B results in increased phosphorylation of AKT2 protein CTD PMID:33940105 Bisphenol B increases expression ISO AKT2 (Homo sapiens) 6480464 bisphenol B results in increased expression of AKT2 protein CTD PMID:34186270 bisphenol F increases expression ISO Akt2 (Mus musculus) 6480464 bisphenol F results in increased expression of AKT2 mRNA CTD PMID:34147605 bromochloroacetic acid increases expression EXP 6480464 bromochloroacetic acid results in increased expression of AKT2 mRNA CTD PMID:16460773 butanal decreases expression ISO AKT2 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of AKT2 mRNA CTD PMID:26079696 Butylbenzyl phthalate increases phosphorylation EXP 6480464 butylbenzyl phthalate results in increased phosphorylation of AKT2 protein CTD PMID:31319113 butyric acid multiple interactions EXP 6480464 Butyric Acid inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased phosphorylation of AKT2 protein] CTD PMID:27270450 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of AKT2 mRNA CTD PMID:19167457 cadmium dichloride affects expression ISO Akt2 (Mus musculus) 6480464 Cadmium Chloride affects the expression of AKT2 mRNA CTD PMID:18974090 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of AKT2 mRNA CTD PMID:33453195 caffeine affects phosphorylation ISO AKT2 (Homo sapiens) 6480464 Caffeine affects the phosphorylation of AKT2 protein CTD PMID:35688186 cannabidiol multiple interactions ISO AKT2 (Homo sapiens) 6480464 [Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of AKT2 mRNA CTD PMID:32992648 carbamazepine affects expression ISO AKT2 (Homo sapiens) 6480464 Carbamazepine affects the expression of AKT2 mRNA CTD PMID:24752500 carbon nanotube increases expression ISO Akt2 (Mus musculus) 6480464 Nanotubes and Carbon analog results in increased expression of AKT2 mRNA CTD PMID:25554681 carmustine decreases expression ISO AKT2 (Homo sapiens) 6480464 Carmustine results in decreased expression of AKT2 mRNA CTD PMID:15980968 chlorpyrifos decreases phosphorylation ISO AKT2 (Homo sapiens) 6480464 Chlorpyrifos results in decreased phosphorylation of AKT2 protein CTD PMID:23994500 cisplatin increases expression ISO AKT2 (Homo sapiens) 6480464 Cisplatin results in increased expression of AKT2 protein CTD PMID:16803524 clenbuterol multiple interactions EXP 6480464 Clenbuterol inhibits the reaction [Oxidopamine results in decreased phosphorylation of AKT2 protein] CTD PMID:16339297 clozapine increases expression EXP 6480464 Clozapine results in increased expression of AKT2 mRNA CTD PMID:15860345 colforsin daropate hydrochloride multiple interactions EXP 6480464 Colforsin inhibits the reaction [Oxidopamine results in decreased phosphorylation of AKT2 protein] CTD PMID:16339297 copper atom decreases expression ISO AKT2 (Homo sapiens) 6480464 Copper results in decreased expression of AKT2 protein CTD PMID:22692975 copper atom multiple interactions ISO AKT2 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in decreased expression of AKT2 mRNA CTD PMID:30911355 copper(0) decreases expression ISO AKT2 (Homo sapiens) 6480464 Copper results in decreased expression of AKT2 protein CTD PMID:22692975 copper(0) multiple interactions ISO AKT2 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in decreased expression of AKT2 mRNA CTD PMID:30911355 cortisol decreases expression ISO AKT2 (Homo sapiens) 6480464 Hydrocortisone results in decreased expression of AKT2 mRNA CTD PMID:31075344 and PMID:32535229 crocin-1 multiple interactions ISO Akt2 (Mus musculus) 6480464 crocin inhibits the reaction [[TNFSF11 protein co-treated with pyrazolanthrone] results in increased expression of AKT2 mRNA] CTD PMID:30580027 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of AKT2 mRNA CTD PMID:26577399 curcumin decreases phosphorylation ISO Akt2 (Mus musculus) 6480464 Curcumin results in decreased phosphorylation of AKT2 protein CTD PMID:36640941 curcumin multiple interactions ISO Akt2 (Mus musculus) 6480464 ATF4 inhibits the reaction [Curcumin results in decreased phosphorylation of AKT2 protein] CTD PMID:36640941 curcumin decreases expression ISO AKT2 (Homo sapiens) 6480464 Curcumin analog results in decreased expression of AKT2 mRNA CTD PMID:26409325 curcumin multiple interactions ISO AKT2 (Homo sapiens) 6480464 4-phenylbutyric acid inhibits the reaction [Curcumin results in decreased phosphorylation of AKT2 protein] more ... CTD PMID:23452621 and PMID:36640941 D-glucose affects response to substance ISO Akt2 (Mus musculus) 6480464 AKT2 protein affects the susceptibility to Glucose CTD PMID:21964073 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of AKT2 mRNA CTD PMID:23914054 dexamethasone multiple interactions ISO Akt2 (Mus musculus) 6480464 Berberine inhibits the reaction [Dexamethasone results in decreased expression of AKT2 mRNA] CTD PMID:20462044 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of AKT2 mRNA CTD PMID:35148621 dexamethasone multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [SMAD5 protein binds to AKT2 gene] CTD PMID:20079400 dexamethasone decreases expression ISO Akt2 (Mus musculus) 6480464 Dexamethasone results in decreased expression of AKT2 mRNA CTD PMID:20462044 diarsenic trioxide decreases response to substance ISO AKT2 (Homo sapiens) 6480464 AKT2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:18048359 diazinon affects expression EXP 6480464 Diazinon affects the expression of AKT2 mRNA CTD PMID:22546817 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of AKT2 mRNA CTD PMID:18636392 diclofenac affects expression ISO AKT2 (Homo sapiens) 6480464 Diclofenac affects the expression of AKT2 mRNA CTD PMID:24752500 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of AKT2 mRNA CTD PMID:22546817 dimethoate decreases phosphorylation ISO AKT2 (Homo sapiens) 6480464 Dimethoate results in decreased phosphorylation of AKT2 protein CTD PMID:23994500 dioxygen multiple interactions ISO AKT2 (Homo sapiens) 6480464 3 more ... CTD PMID:23452621 and PMID:32992648 dioxygen increases expression ISO AKT2 (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of AKT2 protein and Oxygen deficiency results in increased expression of AKT2 protein modified form CTD PMID:23452621 dobutamine multiple interactions EXP 6480464 Dobutamine inhibits the reaction [Oxidopamine results in decreased phosphorylation of AKT2 protein] CTD PMID:16339297 dorsomorphin multiple interactions ISO AKT2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AKT2 mRNA CTD PMID:27188386 doxorubicin affects response to substance ISO AKT2 (Homo sapiens) 6480464 AKT2 protein affects the susceptibility to Doxorubicin CTD PMID:18071906 doxorubicin multiple interactions ISO AKT2 (Homo sapiens) 6480464 [Doxorubicin co-treated with resveratrol] affects the expression of AKT2 mRNA CTD PMID:26969377 doxorubicin affects expression ISO AKT2 (Homo sapiens) 6480464 Doxorubicin affects the expression of AKT2 mRNA CTD PMID:26969377 epoxiconazole decreases expression ISO Akt2 (Mus musculus) 6480464 epoxiconazole results in decreased expression of AKT2 mRNA CTD PMID:35436446 ethanol affects expression EXP 6480464 Ethanol affects the expression of AKT2 mRNA CTD PMID:31039417 and PMID:31075344 ethanol increases expression EXP 6480464 Ethanol results in increased expression of AKT2 mRNA CTD PMID:32535229 ethanol affects splicing ISO Akt2 (Mus musculus) 6480464 Ethanol affects the splicing of AKT2 mRNA CTD PMID:30319688 finasteride increases expression EXP 6480464 Finasteride results in increased expression of AKT2 mRNA CTD PMID:24136188 flutamide increases expression EXP 6480464 Flutamide results in increased expression of AKT2 mRNA CTD PMID:24136188 genistein decreases expression ISO AKT2 (Homo sapiens) 6480464 Genistein results in decreased expression of AKT2 mRNA CTD PMID:15257099 genistein multiple interactions ISO AKT2 (Homo sapiens) 6480464 Genistein inhibits the reaction [Oxygen deficiency results in increased expression of AKT2 protein modified form] and Genistein inhibits the reaction [Oxygen deficiency results in increased expression of AKT2 protein] CTD PMID:23452621 genistein decreases expression ISO Akt2 (Mus musculus) 6480464 Genistein results in decreased expression of AKT2 mRNA CTD PMID:24967385 glucose affects response to substance ISO Akt2 (Mus musculus) 6480464 AKT2 protein affects the susceptibility to Glucose CTD PMID:21964073 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of AKT2 mRNA CTD PMID:15860345 hesperidin multiple interactions EXP 6480464 Hesperidin inhibits the reaction [Paclitaxel results in decreased expression of AKT2 mRNA] CTD PMID:36966900 hesperidin increases expression EXP 6480464 Hesperidin results in increased expression of AKT2 mRNA CTD PMID:36966900 hexachlorobenzene multiple interactions EXP 6480464 [Hexachlorobenzene co-treated with Methylnitrosourea] results in increased phosphorylation of AKT2 protein CTD PMID:22245120 hydralazine multiple interactions ISO AKT2 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of AKT2 mRNA CTD PMID:17183730 hydrogen cyanide decreases expression ISO Akt2 (Mus musculus) 6480464 Hydrogen Cyanide results in decreased expression of AKT2 mRNA CTD PMID:33914522 hydroquinone multiple interactions ISO Akt2 (Mus musculus) 6480464 hydroquinone inhibits the reaction [AKT2 protein results in increased phosphorylation of IRF3 protein] CTD PMID:28883758 insulin multiple interactions ISO AKT2 (Homo sapiens) 6480464 [2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:37005939 inulin multiple interactions ISO Akt2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of AKT2 mRNA CTD PMID:36331819 L-ascorbic acid affects expression ISO AKT2 (Homo sapiens) 6480464 Ascorbic Acid affects the expression of AKT2 mRNA CTD PMID:30597948 lead diacetate increases expression ISO Akt2 (Mus musculus) 6480464 lead acetate results in increased expression of AKT2 mRNA CTD PMID:22609695 and PMID:33932463 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of AKT2 mRNA CTD PMID:30980912 lead(0) decreases expression ISO AKT2 (Homo sapiens) 6480464 Lead results in decreased expression of AKT2 mRNA CTD PMID:19921347 losartan multiple interactions ISO Akt2 (Mus musculus) 6480464 Losartan inhibits the reaction [AGT protein results in increased expression of AKT2 protein] CTD PMID:28578904 maleic acid decreases expression ISO AKT2 (Homo sapiens) 6480464 maleic acid results in decreased expression of AKT2 mRNA CTD PMID:28392987 MeIQ multiple interactions ISO AKT2 (Homo sapiens) 6480464 [2-amino-3 more ... CTD PMID:37005939 MeIQx multiple interactions ISO AKT2 (Homo sapiens) 6480464 [2-amino-3 more ... CTD PMID:37005939 mercury atom decreases expression ISO AKT2 (Homo sapiens) 6480464 Mercury results in decreased expression of AKT2 mRNA CTD PMID:16823088 mercury(0) decreases expression ISO AKT2 (Homo sapiens) 6480464 Mercury results in decreased expression of AKT2 mRNA CTD PMID:16823088 metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased phosphorylation of AKT2 protein] CTD PMID:27270450 methimazole decreases expression ISO Akt2 (Mus musculus) 6480464 Methimazole results in decreased expression of AKT2 mRNA CTD PMID:29990518 methimazole decreases expression ISO AKT2 (Homo sapiens) 6480464 Methimazole results in decreased expression of AKT2 mRNA CTD PMID:29990518 methoxychlor increases expression ISO Akt2 (Mus musculus) 6480464 Methoxychlor results in increased expression of AKT2 mRNA CTD PMID:20829426 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of AKT2 gene CTD PMID:35440735 methylglyoxal multiple interactions ISO Akt2 (Mus musculus) 6480464 [TNFSF11 protein co-treated with Pyruvaldehyde] results in increased expression of AKT2 mRNA and bergenin inhibits the reaction [[TNFSF11 protein co-treated with Pyruvaldehyde] results in increased expression of AKT2 mRNA] CTD PMID:31369791 methylseleninic acid decreases expression ISO AKT2 (Homo sapiens) 6480464 methylselenic acid results in decreased expression of AKT2 mRNA CTD PMID:11830524 microcystin-LR increases expression ISO AKT2 (Homo sapiens) 6480464 cyanoginosin LR results in increased expression of AKT2 mRNA CTD PMID:27796937 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of AKT2 gene CTD PMID:33148267 N-[3-(aminomethyl)benzyl]acetamidine affects response to substance ISO Akt2 (Mus musculus) 6480464 AKT2 protein affects the susceptibility to N-(3-(aminomethyl)benzyl)acetamidine CTD PMID:21964073 N-methyl-N-nitrosourea multiple interactions EXP 6480464 [Hexachlorobenzene co-treated with Methylnitrosourea] results in increased phosphorylation of AKT2 protein CTD PMID:22245120 N-nitrosodiethylamine increases phosphorylation ISO Akt2 (Mus musculus) 127285675 N-nitrosodiethylamine increases phosphorylation of Akt2 protein in liver RGD N-Vinyl-2-pyrrolidone multiple interactions EXP 6480464 [N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of AKT2 mRNA CTD PMID:22037397 nickel atom decreases expression ISO AKT2 (Homo sapiens) 6480464 Nickel results in decreased expression of AKT2 mRNA CTD PMID:25583101 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of AKT2 mRNA CTD PMID:22546817 nicotine increases expression ISO Akt2 (Mus musculus) 6480464 Nicotine results in increased expression of AKT2 mRNA CTD PMID:31945395 nicotine affects expression EXP 6480464 Nicotine affects the expression of AKT2 mRNA CTD PMID:31972234 nitenpyram decreases expression ISO AKT2 (Homo sapiens) 6480464 nitenpyram results in decreased expression of AKT2 mRNA CTD PMID:35568224 nitrofen multiple interactions EXP 6480464 [nitrofen co-treated with Tretinoin] results in increased expression of AKT2 mRNA CTD PMID:20623292 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of AKT2 mRNA CTD PMID:20152353 obeticholic acid decreases expression ISO AKT2 (Homo sapiens) 6480464 obeticholic acid results in decreased expression of AKT2 mRNA CTD PMID:27939613 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of AKT2 mRNA CTD PMID:25729387 oxidopamine multiple interactions EXP 6480464 Clenbuterol inhibits the reaction [Oxidopamine results in decreased phosphorylation of AKT2 protein] more ... CTD PMID:16339297 oxidopamine decreases phosphorylation EXP 6480464 Oxidopamine results in decreased phosphorylation of AKT2 protein CTD PMID:16339297 ozone multiple interactions EXP 6480464 [Coconut Oil co-treated with Ozone] results in decreased expression of AKT2 mRNA more ... CTD PMID:18636392 and PMID:33217375 ozone multiple interactions ISO Akt2 (Mus musculus) 6480464 Ozone promotes the reaction [Soot results in increased phosphorylation of AKT2 protein] CTD PMID:27570198 ozone multiple interactions ISO AKT2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of AKT2 mRNA more ... CTD PMID:32699268 more ... ozone decreases expression EXP 6480464 Ozone results in decreased expression of AKT2 mRNA CTD PMID:33217375 and PMID:33524448 p-menthan-3-ol decreases expression ISO AKT2 (Homo sapiens) 6480464 Menthol results in decreased expression of AKT2 mRNA CTD PMID:26760959 Pachymic acid multiple interactions ISO Akt2 (Mus musculus) 6480464 pachymic acid analog inhibits the reaction [AGT protein results in increased expression of AKT2 protein] CTD PMID:28578904 paclitaxel affects response to substance ISO AKT2 (Homo sapiens) 6480464 AKT2 protein affects the susceptibility to Paclitaxel CTD PMID:18071906 paclitaxel multiple interactions EXP 6480464 Hesperidin inhibits the reaction [Paclitaxel results in decreased expression of AKT2 mRNA] CTD PMID:36966900 paclitaxel decreases expression EXP 6480464 Paclitaxel results in decreased expression of AKT2 mRNA CTD PMID:36966900 paclitaxel increases phosphorylation ISO AKT2 (Homo sapiens) 6480464 Paclitaxel results in increased phosphorylation of AKT2 protein CTD PMID:18071906 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of AKT2 mRNA CTD PMID:33387578 paraquat multiple interactions ISO Akt2 (Mus musculus) 6480464 AKT2 protein affects the reaction [Paraquat results in decreased expression of PPARGC1A protein] and AKT2 protein affects the reaction [Paraquat results in increased expression of NFE2L2 protein] CTD PMID:28115273 paraquat increases response to substance ISO Akt2 (Mus musculus) 6480464 AKT2 protein results in increased susceptibility to Paraquat CTD PMID:28115273 PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:23829299 perfluorododecanoic acid decreases phosphorylation EXP 6480464 perfluorododecanoic acid results in decreased phosphorylation of AKT2 protein CTD PMID:30489073 perfluoroheptanoic acid increases phosphorylation EXP 6480464 perfluoro-n-heptanoic acid results in increased phosphorylation of AKT2 protein CTD PMID:33220336 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of AKT2 protein modified form CTD PMID:28439067 perfluorooctane-1-sulfonic acid multiple interactions ISO Akt2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of AKT2 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of AKT2 mRNA CTD PMID:36331819 perfluoroundecanoic acid decreases phosphorylation EXP 6480464 perfluoroundecanoic acid results in decreased phosphorylation of AKT2 protein CTD PMID:33549592 and PMID:35143807 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of AKT2 gene CTD PMID:33148267 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of AKT2 mRNA CTD PMID:22037397 PhIP multiple interactions ISO AKT2 (Homo sapiens) 6480464 [2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine co-treated with Insulin] results in decreased phosphorylation of AKT2 protein CTD PMID:37005939 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of AKT2 mRNA CTD PMID:19162173 propiconazole decreases expression ISO Akt2 (Mus musculus) 6480464 propiconazole results in decreased expression of AKT2 mRNA CTD PMID:21278054 quercetin decreases expression ISO AKT2 (Homo sapiens) 6480464 Quercetin results in decreased expression of AKT2 mRNA CTD PMID:30152185 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Vincristine results in decreased expression of AKT2 mRNA] CTD PMID:33038355 resveratrol multiple interactions ISO AKT2 (Homo sapiens) 6480464 [Doxorubicin co-treated with resveratrol] affects the expression of AKT2 mRNA more ... CTD PMID:23452621 and PMID:26969377 resveratrol decreases expression ISO AKT2 (Homo sapiens) 6480464 resveratrol results in decreased expression of AKT2 mRNA CTD PMID:26969377 SB 431542 multiple interactions ISO AKT2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AKT2 mRNA CTD PMID:27188386 silicon dioxide increases expression ISO AKT2 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of AKT2 mRNA CTD PMID:23806026 sirolimus multiple interactions ISO AKT2 (Homo sapiens) 6480464 [Sirolimus results in increased activity of AKT2 protein] which results in increased expression of CALD1 protein more ... CTD PMID:17908691 sodium arsenite decreases methylation ISO AKT2 (Homo sapiens) 6480464 sodium arsenite results in decreased methylation of AKT2 gene CTD PMID:25199682 sodium arsenite multiple interactions ISO Akt2 (Mus musculus) 6480464 SEMA3A protein inhibits the reaction [sodium arsenite results in increased phosphorylation of AKT2 protein] and SEMA4A protein promotes the reaction [sodium arsenite results in increased phosphorylation of AKT2 protein] CTD PMID:33290778 sodium arsenite increases phosphorylation ISO Akt2 (Mus musculus) 6480464 sodium arsenite results in increased phosphorylation of AKT2 protein CTD PMID:33290778 sodium arsenite multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AKT2 mRNA and zingerone inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AKT2 mRNA] CTD PMID:36822304 sodium tungstate affects expression ISO AKT2 (Homo sapiens) 6480464 sodium tungstate(VI) affects the expression of AKT2 mRNA CTD PMID:26164860 streptozocin multiple interactions EXP 6480464 [Dietary Fats co-treated with Streptozocin] results in decreased phosphorylation of AKT2 protein more ... CTD PMID:27270450 sulindac decreases expression ISO AKT2 (Homo sapiens) 6480464 Sulindac results in decreased expression of AKT2 mRNA CTD PMID:11906190 sulindac increases expression EXP 6480464 Sulindac results in increased expression of AKT2 mRNA CTD PMID:24136188 tert-butyl hydroperoxide decreases expression ISO AKT2 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in decreased expression of AKT2 mRNA CTD PMID:27509014 tert-butyl hydroperoxide increases methylation ISO AKT2 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased methylation of AKT2 gene CTD PMID:27509014 testosterone increases expression ISO AKT2 (Homo sapiens) 6480464 Testosterone results in increased expression of AKT2 mRNA CTD PMID:21880219 thymoquinone multiple interactions ISO Akt2 (Mus musculus) 6480464 thymoquinone inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of AKT2 protein] CTD PMID:36193556 titanium dioxide increases expression ISO Akt2 (Mus musculus) 6480464 titanium dioxide results in increased expression of AKT2 mRNA CTD PMID:29128614 and PMID:29264374 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of AKT2 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of AKT2 mRNA CTD PMID:25729387 torcetrapib increases expression ISO AKT2 (Homo sapiens) 6480464 torcetrapib results in increased expression of AKT2 mRNA CTD PMID:23228038 triciribine decreases phosphorylation ISO AKT2 (Homo sapiens) 6480464 triciribine results in decreased phosphorylation of AKT2 protein CTD PMID:20857426 triphenylstannane multiple interactions EXP 6480464 [triphenyltin co-treated with ethylene dimethanesulfonate] affects the phosphorylation of AKT2 protein CTD PMID:30772500 Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of AKT2 mRNA CTD PMID:23639586 tunicamycin increases phosphorylation ISO AKT2 (Homo sapiens) 6480464 Tunicamycin results in increased phosphorylation of AKT2 protein CTD PMID:36640941 tunicamycin multiple interactions ISO AKT2 (Homo sapiens) 6480464 Curcumin inhibits the reaction [Tunicamycin results in increased phosphorylation of AKT2 protein] CTD PMID:36640941 valproic acid multiple interactions ISO AKT2 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of AKT2 mRNA more ... CTD PMID:17183730 and PMID:27188386 valproic acid decreases expression ISO Akt2 (Mus musculus) 6480464 Valproic Acid results in decreased expression of AKT2 mRNA CTD PMID:32445665 valproic acid decreases expression ISO AKT2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of AKT2 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO AKT2 (Homo sapiens) 6480464 Valproic Acid affects the expression of AKT2 mRNA CTD PMID:25979313 vincristine decreases expression EXP 6480464 Vincristine results in decreased expression of AKT2 mRNA CTD PMID:33038355 vincristine multiple interactions EXP 6480464 Quercetin inhibits the reaction [Vincristine results in decreased expression of AKT2 mRNA] CTD PMID:33038355 xanthohumol multiple interactions ISO Akt2 (Mus musculus) 6480464 xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of AKT2 mRNA] CTD PMID:23994090 xanthohumol decreases phosphorylation ISO AKT2 (Homo sapiens) 6480464 xanthohumol results in decreased phosphorylation of AKT2 protein CTD PMID:35229981 zinc atom increases expression EXP 6480464 Zinc deficiency results in increased expression of AKT2 mRNA CTD PMID:19111725 zinc(0) increases expression EXP 6480464 Zinc deficiency results in increased expression of AKT2 mRNA CTD PMID:19111725 zingerone multiple interactions EXP 6480464 zingerone inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AKT2 mRNA] CTD PMID:36822304 zingerone increases expression EXP 6480464 zingerone results in increased expression of AKT2 mRNA CTD PMID:36822304